Chemomab Therapeutics Ltd – ADR (CMMB) is near the top in its sector according to InvestorsObserver.
CMMB gets an overall rating of 60. That means it scores higher than 60% of stocks.
Chemomab Therapeutics Ltd – ADR gets a 82 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 60 would rank higher than 60 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.
Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What’s Happening With Chemomab Therapeutics Ltd – ADR Stock Today?
Chemomab Therapeutics Ltd – ADR (CMMB) stock has gained 2.26% while the S&P 500 is lower by -0.82% as of 1:55 PM on Thursday, Jan 5. CMMB has gained $0.06 from the previous closing price of $2.65 on volume of 277,612 shares. Over the past year the S&P 500 is down -18.71% while CMMB is lower by -59.79%. CMMB lost -$33.75 per share the over the last 12 months.
Click Here to get the full Stock Report for Chemomab Therapeutics Ltd – ADR stock.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Read More: Will Chemomab Therapeutics Ltd – ADR (CMMB) Stay at the Top of the Healthcare Sector?